Technical Analysis for OPGN - OpGen, Inc.

Grade Last Price % Change Price Change
grade D 8.0 21.40% 1.41
OPGN closed up 21.4 percent on Friday, September 13, 2019, on 1.91 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Up Up
See historical OPGN trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Wide Bands Range Expansion 21.40%
Crossed Above 50 DMA Bullish 11.42%
Wide Bands Range Expansion 11.42%
Fell Below 50 DMA Bearish 27.19%
20 DMA Support Bullish 27.19%
1,2,3 Pullback Bullish Bullish Swing Setup 27.19%
Calm After Storm Range Contraction 27.19%
Narrow Range Bar Range Contraction 27.19%

Older signals for OPGN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Health Healthcare Providers Pharmaceuticals Policy Antibiotic Bacteria Antimicrobial Resistance Veterinary Medicine Bioinformatics Evolutionary Biology Multi Drug Resistant Bacterial Infections
Is OPGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 48.2
52 Week Low 4.204
Average Volume 315,147
200-Day Moving Average 15.5196
50-Day Moving Average 6.4581
20-Day Moving Average 6.2946
10-Day Moving Average 7.103
Average True Range 1.3078
ADX 51.16
+DI 52.2483
-DI 9.6696
Chandelier Exit (Long, 3 ATRs ) 8.8766
Chandelier Exit (Short, 3 ATRs ) 8.6694
Upper Bollinger Band 8.1662
Lower Bollinger Band 4.423
Percent B (%b) 0.96
BandWidth 59.466845
MACD Line 0.2722
MACD Signal Line 0.1095
MACD Histogram 0.1627
Fundamentals Value
Market Cap 412.41 Million
Num Shares 51.6 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -10.42
Price-to-Sales 5.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.72
Resistance 3 (R3) 11.68 10.40 11.10
Resistance 2 (R2) 10.40 9.45 10.42 10.89
Resistance 1 (R1) 9.20 8.87 9.80 9.24 10.69
Pivot Point 7.92 7.92 8.22 7.94 7.92
Support 1 (S1) 6.72 6.97 7.32 6.76 5.31
Support 2 (S2) 5.44 6.39 5.46 5.11
Support 3 (S3) 4.24 5.44 4.90
Support 4 (S4) 4.28